Rob Jansen
About
Rob Jansen is a scholar working on Physiology, Statistics, Probability and Uncertainty and Statistics and Probability.
According to data from OpenAlex, Rob Jansen has authored 56 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Physiology, 13 papers in Statistics, Probability and Uncertainty and 10 papers in Statistics and Probability. Recurrent topics in Rob Jansen's work include Clinical Laboratory Practices and Quality Control (33 papers), Statistical Methods in Clinical Trials (8 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Rob Jansen is often cited by papers focused on Clinical Laboratory Practices and Quality Control (33 papers), Statistical Methods in Clinical Trials (8 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Rob Jansen collaborates with scholars based in Netherlands, Germany and Italy. Rob Jansen's co-authors include Mauro Panteghini, Ken Sikaris, Christa M. Cobbaert, Cas Weykamp, Andrea R. Horvath, Callum G. Fraser, Per Hyltoft Petersen, Sverre Sandberg, Wytze P. Oosterhuis and Heinz Schimmel and has published in prestigious journals such as Nature, Clinical Chemistry and Analytica Chimica Acta.
In The Last Decade
Rob Jansen
56 papers receiving 1.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Rob Jansen Netherlands | 21 | 798 | 461 | 260 | 218 | 144 | 56 | 1.4k | ||
| Wytze P. Oosterhuis Netherlands | 22 | 767 1.0× | 556 1.2× | 297 1.1× | 184 0.8× | 287 2.0× | 64 | 1.7k | ||
| Carmen Perich Spain | 20 | 752 0.9× | 424 0.9× | 178 0.7× | 221 1.0× | 68 0.5× | 41 | 1.2k | ||
| Carmen Ricós Spain | 27 | 1.4k 1.8× | 794 1.7× | 318 1.2× | 432 2.0× | 169 1.2× | 74 | 2.3k | ||
| George S. Cembrowski Canada | 22 | 550 0.7× | 271 0.6× | 192 0.7× | 150 0.7× | 148 1.0× | 104 | 1.7k | ||
| Anna Carobene Italy | 29 | 1.0k 1.3× | 504 1.1× | 269 1.0× | 333 1.5× | 106 0.7× | 99 | 2.3k | ||
| Thomas Røraas Norway | 18 | 588 0.7× | 302 0.7× | 213 0.8× | 235 1.1× | 52 0.4× | 28 | 1.2k | ||
| Federica Braga Italy | 29 | 920 1.2× | 529 1.1× | 407 1.6× | 290 1.3× | 119 0.8× | 63 | 2.2k | ||
| Jorge Díaz–Garzón Spain | 22 | 717 0.9× | 390 0.8× | 200 0.8× | 283 1.3× | 55 0.4× | 61 | 1.3k | ||
| Abdurrahman Coşkun Türkiye | 29 | 1.1k 1.4× | 588 1.3× | 325 1.3× | 356 1.6× | 131 0.9× | 141 | 2.3k | ||
| Joana Minchinela Spain | 16 | 621 0.8× | 337 0.7× | 147 0.6× | 189 0.9× | 48 0.3× | 34 | 996 |
Countries citing papers authored by Rob Jansen
Since
Specialization
Citations
This map shows the geographic impact of Rob Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Jansen more than expected).
Fields of papers citing papers by Rob Jansen
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Rob Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Jansen. The network helps show where Rob Jansen may publish in the future.
Co-authorship network of co-authors of Rob Jansen
This figure shows the co-authorship network connecting the top 25 collaborators of Rob Jansen. A scholar is included among the top collaborators of Rob Jansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob Jansen. Rob Jansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Thelen, Marc, et al.. (2017). Expressing analytical performance from multi-sample evaluation in laboratory EQA. Clinical Chemistry and Laboratory Medicine (CCLM). 55(10). 1509–1516.
2.
Kuypers, Aldy W.H.M., et al.. (2014). A Multilaboratory Commutability Evaluation of Proficiency Testing Material for Carbamazepine and Valproic Acid. Therapeutic Drug Monitoring. 37(4). 445–450.
3.
Bais, Renze, et al.. (2013). Defining acceptable limits for the metrological traceability of specific measurands. Clinical Chemistry and Laboratory Medicine (CCLM). 51(5). 973–9.
4.
Perich, Carmen, Carmen Ricós, Virtudes Álvarez, et al.. (2013). External quality assurance programs as a tool for verifying standardization of measurement procedures: Pilot collaboration in Europe. Clinica Chimica Acta. 432. 82–89.
5.
Cobbaert, Christa M., Cas Weykamp, Paul Franck, et al.. (2012). Systematic monitoring of standardization and harmonization status with commutable EQA-samples—Five year experience from the Netherlands. Clinica Chimica Acta. 414. 234–240.
6.
Kroot, Joyce JC, Antonius E. van Herwaarden, Harold Tjalsma, et al.. (2012). Second round robin for plasma hepcidin methods: First steps toward harmonization. American Journal of Hematology. 87(10). 977–983.
7.
Delanghe, Joris, Christa M. Cobbaert, Marie‐Madeleine Galteau, et al.. (2008). Trueness verification of actual creatinine assays in the European market demonstrates a disappointing variability that needs substantial improvement. An international study in the framework of the EC4 creatinine standardization working group. Clinical Chemistry and Laboratory Medicine (CCLM). 46(9). 1319–25.
8.
Jansen, Rob, G. Schumann, H Baadenhuijsen, et al.. (2006). Trueness verification and traceability assessment of results from commercial systems for measurement of six enzyme activities in serum. Clinica Chimica Acta. 368(1-2). 160–167.
9.
Sanders, Gerard T., J R McMurray, V. Blaton, et al.. (2004). The European Register for Specialists in Clinical Chemistry and Laboratory Medicine: Code ofConduct. Clinical Chemistry and Laboratory Medicine (CCLM). 42(5). 563–5.
10.
Gurr, Eberhard, Ursula Köller, V. Blaton, et al.. (2003). The European Register for Specialists in Clinical Chemistry and Laboratory Medicine: Guide to the Register Version 2-2003 and Procedure for Re-registration. Clinical Chemistry and Laboratory Medicine (CCLM). 41(2). 238–47.
11.
Jansen, Rob, et al.. (2002). Internal Quality Control System for Non-Stationary, Non-Ergodic Analytical Processes Based upon Exponentially Weighted Estimation of Process Means and Process Standard Deviation. Clinical Chemistry and Laboratory Medicine (CCLM). 40(6). 616–24.
12.
Baadenhuijsen, H, et al.. (2002). Commutability Assessment of Potential Reference Materials Using a Multicenter Split-Patient-Sample Between-Field-Methods (Twin-Study) Design: Study within the Framework of the Dutch Project “Calibration 2000”. Clinical Chemistry. 48(9). 1520–1525.
13.
Jansen, Rob, Desmond Kenny, David Burnett, et al.. (2000). Usefulness of EC4 Essential Criteria for Quality Systems of Medical Laboratories as Guideline to the ISO 15189 and ISO 17025 Documents. Clinical Chemistry and Laboratory Medicine (CCLM). 38(10). 1057–1064.
14.
Baadenhuijsen, H, et al.. (2000). A model for harmonization of routine clinical chemistry results between clinical laboratories. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 37(3). 330–337.
15.
Sanders, Gerard T., Rob Jansen, G. H. Beastall, et al.. (1999). Recent Activities of EC4 in the Harmonization of Clinical Chemistry in the European Union. Clinical Chemistry and Laboratory Medicine (CCLM). 37(4). 477–480.
16.
Jansen, Rob, et al.. (1998). Additional Essential Criteria for Quality Systems of Medical Laboratories. Clinical Chemistry and Laboratory Medicine (CCLM). 36(4). 249–252.
17.
Haeckel, Rainer, et al.. (1998). Concepts for a Model of Good Medical Laboratory Services. Clinical Chemistry and Laboratory Medicine (CCLM). 36(6). 399–403.
18.
Demacker, Pierre N.M., et al.. (1994). A case of hyperalphalipoproteinemia associated with albumin complexing. Atherosclerosis. 111(1). 13–23.
19.
Jansen, Rob, et al.. (1993). Between-Country Comparability of Clinical Chemistry Results: An International Quality Assessment Survey of 17 Analytes in Six European Countries through Existing National Schemes. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 30(3). 304–314.
20.
Demacker, Pierre N.M., et al.. (1982). Intra-individual variation of serum cholesterol, triglycerides and high density lipoprotein cholesterol in normal humans. Atherosclerosis. 45(3). 259–266.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Wytze P. Oosterhuis Breakdown of academic impact, for papers by Carmen Perich Breakdown of academic impact, for papers by Carmen Ricós Breakdown of academic impact, for papers by George S. Cembrowski Breakdown of academic impact, for papers by Anna Carobene Breakdown of academic impact, for papers by Thomas Røraas Breakdown of academic impact, for papers by Federica Braga Breakdown of academic impact, for papers by Jorge Díaz–Garzón Breakdown of academic impact, for papers by Abdurrahman Coşkun Breakdown of academic impact, for papers by Joana Minchinela